Diabetic Peripheral Neuropathy

Speak For Your Feet Contest for Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathy (DPN), or nerve damage caused by diabetes, is one of the most known causes of neuropathy. DPN can be a common complication that affects the extremities and normally presents itself as a loss of sensation, most often described as numbness and tingling. Symptoms of DPN can also cause debilitating pain which is …

Speak For Your Feet Contest for Diabetic Peripheral Neuropathy Read More »

Join The Speak For Your Feet Contest!

More than 37 million people in the U.S. live with diabetes today. 1 And for many of them, nerve damage caused by diabetes – a condition called diabetic peripheral neuropathy or diabetic nerve pain – is a common complication that most often affects the lower extremities and normally presents itself as tingling, numbness, burning, shooting …

Join The Speak For Your Feet Contest! Read More »

AAN’s New Painful Diabetic Polyneuropathy Guidelines

A study entitled “Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary” was published on December 29, 2021, in the journal Neurology®. The Foundation for Peripheral Neuropathy (FPN) is pleased to announce that Lindsay Colbert, Executive Director, was among the few esteemed authors on the subcommittee for this important review and update. …

AAN’s New Painful Diabetic Polyneuropathy Guidelines Read More »

Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain

Erchonia Corporation is currently recruiting for a study on the effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy pain. This study can be found at ClinicalTrials.gov here. PURPOSE OF THE STUDY In this study, the Sponsor, Erchonia Corporation, and investigators are studying the use of a device called the Erchonia® FX-635™ that gives …

Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain Read More »

diabetic peripheral neuropathy treatment

Research Study for Painful Diabetic Peripheral Neuropathy

Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy. Aptinyx Inc. is conducting a research study evaluating multiple doses of its investigational drug NYX-2925 versus placebo in treating the neuropathic pain associated with diabetic peripheral neuropathy. Enrollment into this …

Research Study for Painful Diabetic Peripheral Neuropathy Read More »

Clinical Trial

Clinical Trial for Diabetic Peripheral Neuropathy

Northwestern University is conducting a Phase III clinical trial with Viromed Pharmaceuticals for an investigational drug (VM202) on painful, diabetic peripheral neuropathy in the legs and feet. This drug has been shown to be safe and effective at reducing pain caused by neuropathy through the generation of new blood vessels and nerves. The basic inclusion/exclusion …

Clinical Trial for Diabetic Peripheral Neuropathy Read More »

diabetic peripheral neuropathy treatment

Treating Painful Diabetic Peripheral Neuropathy: An Update

Summary of journal article reviewing the current state of diabetic peripheral neuropathy treatment: Painful diabetic peripheral neuropathy occurs in approximately 25% of patients with diabetes mellitus who are treated in the office setting and significantly affects quality of life. It typically causes burning pain, paresthesias, and numbness in a stocking-glove pattern that progresses proximally from …

Treating Painful Diabetic Peripheral Neuropathy: An Update Read More »

diabetic peripheral neuropathy

Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial

VM BioPharma, the United States division of ViroMed Co., Ltd. in Seoul, Korea, announced the first patient was dosed in the recently initiated Phase 3 clinical study evaluating VM202, a proprietary DNA-based biopharmaceutical, in patients with painful diabetic peripheral neuropathy (DPN). This is the first pivotal gene therapy trial specifically targeting the most common cause …

Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial Read More »

Small Nerve Fibers Defy Neuropathy Conventions

Peripheral neuropathy research study suggests even prediabetes could cause nerve damage. Peripheral neuropathy research results of a small study of people with tingling pain in their hands and feet have added to evidence that so-called prediabetes is more damaging to motor nerves than once believed. The report on the study was published online in JAMA …

Small Nerve Fibers Defy Neuropathy Conventions Read More »

FPN Connects Peripheral Neuropathy Researchers at Astellas Pharma to the Patients They Are Hoping to Serve

On December 3, 2015, Astellas Pharma US, Inc. (the U.S. affiliate of Astellas Pharma Inc.), a R&D-driven global pharmaceutical company, invited the Foundation for Peripheral Neuropathy to present to a global team working on development of ASP3662 for patients with neuropathic pain (NP). This was an internal meeting, which included Ulf Tollemar, Executive Director, Development …

FPN Connects Peripheral Neuropathy Researchers at Astellas Pharma to the Patients They Are Hoping to Serve Read More »

Send this to a friend